First Midwest Bank Trust Division’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | $2.5M | Buy |
40,035
+2,802
| +8% | +$164K | 0.32% | 78 |
|
|
2021
Q3 | $2.2M | Sell |
37,233
-7,158
| -16% | -$471K | 0.31% | 77 |
|
|
2021
Q2 | $2.97M | Sell |
44,391
-2,552
| -5% | -$166K | 0.4% | 60 |
|
|
2021
Q1 | $2.96M | Sell |
46,943
-4
| -0% | -$249 | 0.41% | 60 |
|
|
2020
Q4 | $2.91M | Sell |
46,947
-1,013
| -2% | -$62.3K | 0.42% | 63 |
|
|
2020
Q3 | $2.89M | Sell |
47,960
-1,050
| -2% | -$63.2K | 0.45% | 57 |
|
|
2020
Q2 | $2.88M | Sell |
49,010
-809
| -2% | -$48.4K | 0.47% | 51 |
|
|
2020
Q1 | $2.78M | Sell |
49,819
-763
| -2% | -$46.6K | 0.51% | 42 |
|
|
2019
Q4 | $3.25M | Buy |
50,582
+22,848
| +82% | +$1.31M | 0.44% | 56 |
|
|
2019
Q3 | $1.41M | Buy |
27,734
+2,999
| +12% | +$141K | 0.2% | 124 |
|
|
2019
Q2 | $1.12M | Sell |
24,735
-1,899
| -7% | -$88.5K | 0.16% | 152 |
|
|
2019
Q1 | $1.27M | Sell |
26,634
-4
| -0% | -$199 | 0.17% | 143 |
|
|
2018
Q4 | $1.39M | Sell |
26,638
-2,246
| -8% | -$121K | 0.21% | 127 |
|
|
2018
Q3 | $1.79M | Sell |
28,884
-5,409
| -16% | -$321K | 0.24% | 111 |
|
|
2018
Q2 | $1.9M | Sell |
34,293
-4,015
| -10% | -$217K | 0.27% | 103 |
|
|
2018
Q1 | $2.42M | Buy |
38,308
+9,308
| +32% | +$599K | 0.33% | 77 |
|
|
2017
Q4 | $1.78M | Sell |
29,000
-494
| -2% | -$30.9K | 0.22% | 122 |
|
|
2017
Q3 | $1.88M | Sell |
29,494
-3,204
| -10% | -$187K | 0.23% | 116 |
|
|
2017
Q2 | $1.82M | Sell |
32,698
-3,045
| -9% | -$166K | 0.22% | 125 |
|
|
2017
Q1 | $1.94M | Sell |
35,743
-44,462
| -55% | -$2.44M | 0.24% | 121 |
|
|
2016
Q4 | $4.69M | Buy |
80,205
+51,535
| +180% | +$2.82M | 0.56% | 36 |
|
|
2016
Q3 | $1.54M | Sell |
28,670
-5,561
| -16% | -$357K | 0.19% | 161 |
|
|
2016
Q2 | $2.52M | Sell |
34,231
-1,935
| -5% | -$137K | 0.31% | 95 |
|
|
2016
Q1 | $2.31M | Buy |
36,166
+1,741
| +5% | +$110K | 0.3% | 100 |
|
|
2015
Q4 | $2.37M | Buy |
34,425
+4,493
| +15% | +$297K | 0.4% | 76 |
|
|
2015
Q3 | $1.77M | Sell |
29,932
-125
| -0.4% | -$7.93K | 0.31% | 93 |
|
|
2015
Q2 | $2M | Buy |
30,057
+1,215
| +4% | +$80.1K | 0.32% | 89 |
|
|
2015
Q1 | $1.86M | Buy |
28,842
+1,612
| +6% | +$101K | 0.29% | 101 |
|
|
2014
Q4 | $1.61M | Buy |
27,230
+750
| +3% | +$42.3K | 0.25% | 118 |
|
|
2014
Q3 | $1.36M | Sell |
26,480
-2,490
| -9% | -$124K | 0.22% | 131 |
|
|
2014
Q2 | $1.41M | Sell |
28,970
-804
| -3% | -$39.6K | 0.22% | 131 |
|
|
2014
Q1 | $1.55M | Buy |
29,774
+1,300
| +5% | +$69.2K | 0.25% | 122 |
|
|
2013
Q4 | $1.51M | Sell |
28,474
-1,200
| -4% | -$61.1K | 0.27% | 116 |
|
|
2013
Q3 | $1.37M | Sell |
29,674
-836
| -3% | -$36.7K | 0.27% | 112 |
|
|
2013
Q2 | $1.36M | Buy |
+30,510
| New | +$1.32M | 0.27% | 113 |
|
Other funds holding BMY
First Midwest Bank Trust Division's BMY Position: Q4 2021 in Review
First Midwest Bank Trust Division increased its Bristol-Myers Squibb (BMY) stake by 7.5% in Q4 2021, buying an estimated $164K and bringing the position to 40,035 shares worth $2.5M. The position accounts for 0.32% of the portfolio, ranked #78.
First Midwest Bank Trust Division first reported a position in BMY in Q2 2013 and has held it in 35 quarters since. The position peaked at $4.69M in Q4 2016. 2,444 funds tracked by Wall St. Rank hold BMY as of Q4 2021.
- First Midwest Bank Trust Division held 40,035 shares of Bristol-Myers Squibb worth $2.5M as of Q4 2021.
- First Midwest Bank Trust Division bought 2,802 Bristol-Myers Squibb shares in Q4 2021, an estimated $164K.
- Bristol-Myers Squibb made up 0.32% of First Midwest Bank Trust Division's portfolio in Q4 2021, its #78 holding.
- First Midwest Bank Trust Division first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 35 quarters since.
- First Midwest Bank Trust Division's Bristol-Myers Squibb position peaked at $4.69M in Q4 2016.
- 2,444 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2021.
Based on First Midwest Bank Trust Division's 13F filing for Q4 2021, filed 18 Jan 2022.